Market News
Global Cholera Vaccines Market - Recent Developments
Vaccination Campaigns
- On January 29, 2024, the Government of Zimbabwe launched a vaccination campaign against cholera in collaboration with UNICEF and the World Health Organization (WHO). The first cholera vaccines were administered by the Health and Child Care Honorable Minister, Dr Douglas Mombeshora during an event in Kuwadzana.
- On December 13, 2023, health authorities in the Congo and international health partners launched a vaccination campaign against cholera that is targeting more than 5 million residents in four provinces. The launch of this mass campaign against cholera with the use of the oral vaccine in the targeted provinces will help protect a significant number of people in vulnerable situations and is also crucial to prevent the further spread of the disease to other fragile and exposed areas.
Fundings
- In July 2022, the U.S. Agency for International Development (USAID) provided nearly US$ 1,180 million surge in humanitarian assistance that allowed USAID partners to provide critical aid for millions of people across the region. This funding includes urgent health support and investigations to identify potential diseases, such as cholera. As the risk for infectious disease increases when water sources are contaminated, USAID is providing water, sanitation, and hygiene support in drought-affected areas to include safe, potable water through water trucking, repaired water boreholes, community wells, and distribution systems.
Partnership and Collaboration
- On May 16, 2023, Techinvention, a biotechnology company, announced a partnership with EUBIOLOGICS CO., LTD., a pharmaceutical company, to launch Euvichol-Plus, the oral cholera vaccine, in a low-density polyethylene (LDPE) unidose pack in India
- In November 2022, co.za., South Africa-based bio-pharmaceutical company announced a licensing and technology transfer collaboration agreement with the International Vaccine Institute (IVI), a non-profit international organization headquartered in South Korea, for the manufacturing of an oral cholera vaccine (OCV) to reduce the critical shortage of vaccines needed to prevent cholera globally
U.S.: 
U.K. : 
India : 
